Details for New Drug Application (NDA): 018649
✉ Email this page to a colleague
NDA 018649 describes THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 018649
| Tradename: | THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018649
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 40MG/100ML | ||||
| Approval Date: | Jul 26, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 80MG/100ML | ||||
| Approval Date: | Jul 26, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 160MG/100ML | ||||
| Approval Date: | Jul 26, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
